Skip to main content
Top

Supportive Care in Cancer

Issue 1/2002

Content (13 Articles)

Supportive Care International

Supportive and palliative care: experience at the Institut Jules Bordet

I. Mancini, D. Lossignol, M. Obiols, R. Llop, C. Toth, J. Body

Special Article

Supportive Care in Cancer – 15 years thereafter

Hans-Jörg Senn, Agnes Glaus

Review Article

Morphine in cancer pain management: a practical guide

Sinead Donnelly, Mellar P. Davis, Declan Walsh, Michael Naughton

Review Article

Management of oral disease prior to radiation therapy

Morten Schiødt, Niels Hermund

Original Article

Does awareness of diagnosis make any difference to quality of life?

H. Bozcuk, V. Erdoğan, C. Eken, E. Çıplak, M. Samur, M. Özdoğan, B. Savaş

Original Article

Physical compatibility and in vivo evaluation of drug mixtures for subcutaneous infusion to cancer patients in palliative care

Sofía Negro, María Azuara, Yolanda Sánchez, Rodrigo Reyes, Emilia Barcia

Original Article

Does megestrol acetate down-regulate interleukin-6 in patients with cancer-associated anorexia and weight loss? A North Central Cancer Treatment Group investigation

Aminah Jatoi, Jun-ichi Yamashita, Jeff A. Sloan, Paul J. Novotny, Harold E. Windschitl, Charles L. Loprinzi

Original Article

Cost–benefit assessment of inferior vena cava filter placement in advanced cancer patients

Pierre-Yves Marcy, Nicolas Magné, Jean-Claude Gallard, Pierre-Yves Bondiau, Marc Frenay, Bertrand Descamps

Short Communication

Relapsed, poor-prognosis ovarian cancer, individualized, interdisciplinary treatment approach, and quality of life: a case report

Catharina C. Wenzel, Manuela P. Schmidinger, Gottfried J. Locker, Raimund Jakesz, Guenther G. Steger

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine